#CBR Systems Stem Cell Banking Market

[bishtmeenakshi]

3 Key Insights on US$ 15 Bn Opportunity in the Global Stem Cell Banking Market - Ken Research

Driven By the increasing prevalence of infectious diseases and rising individuals’ awareness regarding the therapeutic potentials of stem cells, the Global Stem Cell Banking Market is forecasted to Cross US$ 15 Bn by 2028 says Ken Research Study.

Stem Cell Banking is the collection and cryogenic storage of stem cells from a newborn infant's umbilical cord blood and tissue which can be further used in cell treatments or clinical trials. It has the potential to treat a wide range of diseases, as well as the ability to mortgage stem cells from multiple family members and use an individual’s own stem cells (autologous transplant). Furthermore, individuals with spinal cord injuries, type 1 diabetes, Parkinson's disease, amyotrophic lateral sclerosis, Alzheimer's disease, heart disease, stroke, burns, cancer, and osteoarthritis may also benefit from stem cell therapies.

“Ken Research shares 3 key insights on this high opportunity market from its latest research study”

Stem Cell Banking Market Continues to Grow Owing to The Growing Newborn Population Worldwide.

The Global Stem Cell Banking Market is expected to witness stable growth during the forecast period, owing to the increasing newborn population, and rising individuals’ awareness regarding the therapeutic potentials of stem cells. The global stem cell banking market was valued at ~US$ 4 billion in 2017, it is estimated to be ~US$ 7 billion in 2022 and is expected to reach a market size of ~US$ 15 billion by 2028 growing with a CAGR of ~12%.

North America is the dominating region in the Global Stem Cell Banking Market due to the increasing incidence rates of diseases, such as cancer, neurological disorders, and diabetes. Furthermore, the growing government initiatives and investments in stem cell therapies are contributing to the region's growth in stem cell banking.

To learn more about this report Download A Free Sample Report

The Rising Prevalence of fatal Chronic Diseases, Such as Cancer, Cardiovascular Diseases, Neurological Disorders, Immunological Disorders, and Other Rare Metabolic Diseases is Propelling the Market Growth of Stem Cell Banking.

The growing geriatric population worldwide, who are more exposed to chronic and infectious diseases, including immunological disorders is propelling the stem cell banking market. In addition, the increasing prevalence of cancer, cardiovascular diseases, and autoimmune diseases, such as type 1 diabetes, and nephrological diseases is widening the use of stem cells as a potential treatment option.

For instance, according to Scientific American, an American science magazine that covers science, health, and social justice issues, several autoimmune diseases affected nearly 4.5% of the world's population in 2021.

According to the World Health Organization (WHO), a United Nations agency responsible for global public health, nearly 18 million people die every year as a result of cardiovascular diseases.

Visit This Link: - Request For Custom Report

High Operational Cost Associated with Stem Cell Banking, along with the stringent regulatory Frameworks May Impede the Market Growth of Stem Cell Banking.

Stem cell therapies have grown in popularity in recent years as individuals seek out alternative treatments for a variety of chronic diseases. Every day, new types of therapies are introduced, and individuals from all over the world are turning to them in place of traditional drug treatments and hospital visits. Despite the significant increase in demand for stem cell therapies, they remain prohibitively expensive to pursue. Simple joint injections cost close to US$ 5000, and more advanced treatments cost up to US$ 100,000, depending on the condition.

Furthermore, the stem cell field remains highly specialized and has yet to be adopted by citizens or insurance companies. Additionally, the field is further limited by older laws in some countries, most notably the United States. That means that there are relatively few sources for stem cells, and labs equipped to perform stem cells.

Request Free 30 Minutes Analyst Call

Key Topics Covered in the Report

Snapshot of the Global Stem Cell Banking Market

Industry Value Chain and Ecosystem Analysis

Market size and Segmentation of the Global Stem Cell Banking Market

Historic Growth of the Overall Global Stem Cell Banking Market and Segments

Competition Scenario of the Market and Key Developments of Competitors

Porter’s 5 Forces Analysis of the Global Stem Cell Banking Industry

Overview, Product Offerings, and Strengths & Weaknesses of Key Competitors

Covid-19 Impact on the Overall Global Stem Cell Banking Market

Future Market Forecast and Growth Rates of the Total Global Stem Cell Banking Market and by Segments

Market Size of Source, Service Type, Application, Cell Type Segments with Historical CAGR and Future Forecasts

Analysis of the Global Stem Cell Banking Market

Major Production/Supply and Consumption/Demand Hubs within Each Region

Major Country-wise Historic and Future Market Growth Rates of the Total Market and Segments

Overview of Notable Emerging Competitor Companies within Each Region

Notable Key Players Mentioned in the Report

CBR Systems, Inc.

Cryo-Cell International, Inc.

ViaCord

Sartorius AG

StemCyte, Inc.

Smart Cells International Limited

Global Cord Blood Corporation

Vita 34

LifeCell International Pvt. Ltd

Cordlife Group Limited

Notable Emerging Companies Mentioned in the Report

CyroHoldco

Generate Life Sciences Inc.

Hope Biosciences

Cell Care

ReeLabs Pvt. Ltd.

BrainStorm Cell Therapeutics, Inc.

CellSave a CSG-BIO Company, Inc.

Bristol-Myers Squibb Company

Key Target Audience – Organizations and Entities Who Can Benefit by Subscribing This Report

Stem Cell Banking Companies

Biopharmaceuticals Companies

Cord Blood Banks

Machinery and Equipment Suppliers for Stem Cell Banking

Cryogenic Healthcare Equipment Manufacturers

Biotechnology - Therapeutics and Diagnostics Companies

Pharmaceutical Companies

World Marrow Donor Association

Cord Blood Association

The International Stem Cell Banking Initiative (ISCBI) – PubMed

Healthcare Research Institutes

Healthcare Technology Research Institutes

Healthcare Technology Regulatory Authorities

Government Ministries and Departments of Healthcare

Period Captured in the Report

Historical Period: 2017-2021

Forecast Period: 2022E-2028F

For more insights on the market intelligence, refer to the link below: -

Global Stem Cell Banking Market

Related Reports By Ken Research: -

Global Stem Cell Banking Market Outlook to 2028

[iruchakalyan]

The Global Cord Blood Banking Services Market was valued at USD 33.8 Billion in 2023 and is estimated to reach USD 65.9 Billion by 2033, growing at a CAGR of 7.9 % from 2024 to 2033

Cord Blood contains a very rich source of stem cells that can treat more than 80 diseases. This is the process of collecting life-saving stem cells placenta and umbilical cord and storing them for future use. These stem cells can be used in treating chronic diseases such as blood disease, cancer, diabetes, immune disease, and genetic disorders. These cells are mainly collected from hospitals, and nursing homes and are stored in a cord blood bank for future use up to 25 years. The government has taken the initiative to support research and clinical trials of cord blood stem cells, this support is driving the interest of investment from healthcare companies and commercialization of cord blood stem cell therapies. Moreover, the rise in autoimmune diseases and rising awareness of therapeutics of stem cells are propelling the growth of the market.

The technical improvement in stem cell research and development, storage procedure, and cryopreservation techniques is giving new opportunities to key players to invest in this Cord Blood Banking Service Market.

Furthermore, the rising prices for storing cord blood banking may restrict the market. A patient has to pay for storing and maintenance charges yearly and health insurance companies do not cover cord blood banking which hinders the growth of the market to expand in the forecast period. In 2022, FemiCord group said that within Europe the number of cord banks had dropped by more than 1/3rd over the past decade.

The rising awareness of cord blood stem cell therapy are major factor that drives the market growth. For instance, the automated processing and storage of cord blood has improved the cost and customer convenience.

Economic Impact of Covid-19:

The analysis of the COVID-19 recovery trajectory provides an overview of the main strategies that industries are implementing to respond to and recover from the economic crisis. It also focuses on the post-pandemic and pre-pan\demic era of the Global Cord Blood Banking Services Market through PEST analysis, SWOT, Quantitative and Qualitative analysis, Attractive analysis, and DROs. Innovations by market players and an increasing number of products will propel the growth of this market.

The COVID-19 outbreak has affected the growth of this market due to the lockdown and this delay in the supply and collection of cord blood that is used to treat disease.  The number of chronic patients increasing day by day is the major restraining factor of the Cord Blood Banking Services Market.

Key Players:

LifeCell

StemCyte Inc.

BrainStorm Cell Limited

Celgene Corporation

Cryo-Cell International

Cordlife Group Limited

Singapore Cord Blood Bank

Cryo-Save Group AV

Cord Blood America Inc.

CBR Systems Inc.

ViaCord Inc

China Cord Blood Corporation

AMAG Pharmaceuticals Inc.

Americord Registry LLC

Esperite N.V.

Others

Know More- https://nexbindinsight.com/pharmaceutical-and-healthcare/the-global-cord-blood-banking-services-market-was-valued-at

[ken-research-market-research]

Global Stem Cell Banking Market Research Report & Outlook To 2023: Ken Research

Global Stem Cell Banking Market Research Report & Outlook To 2023: Ken Research

The stem cells are undistinguishable biological cells that can differentiate into particular cells, tissue or an organ. Nearly 500 stem cell banks are performing across the globe, and every bank is now struggling harder to rise their market share. Whereas, the procedure of keeping these stem cells for the treatment of life threatening diseases in the future is called stem cell banking. The stem…

[healthcaretrendingtopics-blog]

Cord Blood Banking Services Market Dynamics, Comprehensive Analysis, Business Growth, Prospects and Opportunities by 2023

Overview:

The global cord blood banking services market is expected to exhibit a robust 11.4% CAGR over the forecast period from 2017 to 2023, according to a new report from Market Research Future (MRFR). The global cord blood baking services market is likely to be driven by the growing research into the medical utility of stem cells and cord blood, and the growing establishment of the infrastructure required to create a strong cord blood banking services network.

Get Free Sample PDF @ https://www.marketresearchfuture.com/sample_request/5817

The growing realization of the utility of stem cells in treating a number of metabolic, immune, and blood disorders is likely to be a major driver for the global cord blood banking services market over the forecast period. Stem cells retain the basic genetic structure of an individual in the form of pluripotent cells that can be turned into a wide variety of cell types within the human body. This has made them highly important in the research field of diseases such as blood-related diseases, immune system diseases, cancers, and metabolic disorders. Cord blood banking remains the most effective way of acquiring, storing, and harnessing stem cells, making the cord blood banking services market likely to grow over the forecast period.

The rising government support to the cord blood banking services sector and increasing private investment in the field are also likely to be vital for the global cord blood banking services market over the forecast period. Due to the fragile and perishable nature of cord blood and stem cells, adequate storage infrastructure has to be put in place before efforts are made to retrieve and acquire stem cells from cord blood. Like regular blood, cord blood and stem cells also require significant efforts in terms of refrigeration and hygiene in order to maintain the stem cells in a viable form. The growing government support to expansion of the healthcare sector and increase in the adoption of and research into stem cells is likely to be a major driver for the global cord blood banking services market over the forecast period.

Segmentation:

The global cord blood banking services market has been segmented on the basis of storage service, component, application, end user, and region.

On the basis of storage service, the global cord blood banking services market is segmented into public cord blood banks, private cord blood banks, and hybrid cord blood banks.

On the basis of component, the global cord blood banking services market is segmented into cord blood, cord tissue, placenta, and others.

On the basis of application, the global cord blood banking services market is segmented into cancers, blood disorders, metabolic disorders, immune disorders, and osteoporosis.

On the basis of end user, the global cord blood banking services market is segmented into hospitals, pharmaceutical research, research institutes, and others.

Browse Complete Report @ https://www.marketresearchfuture.com/reports/cord-blood-banking-services-market-5817

Regional Analysis:

The global cord blood banking services market is segmented by region into the Americas, Europe, Asia Pacific, and the Middle East and Africa.

The Americas, followed by Europe, is expected to retain the dominant share in the global cord blood banking services market over the forecast period due to the widespread adoption of cord blood banking services in the region. Research efforts in the use of stem cells for medical purposes are also rife in the region, leading to strong growth prospects for the cord blood banking services market in the region. The increasing awareness about the utility of stem cells in treating a wide range of disorders in North America is also likely to be a major driver for the cord blood banking services market in the Americas over the forecast period. Europe is also likely to retain a significant share in the global cord blood banking services market over the forecast period due to the growing use of stem cells in medical applications and growth in the related infrastructure.

Competitive Analysis:

Leading players in the global cord blood banking services market include China Cord Blood Corporation, CBR Systems Inc., Virgin Health Bank, Vita 34 International, Stem Cell Cryobank Inc., and Americord Registry.

Industry Updates:

In January 2019, Cellular Engineering Technologies and the John Paul II Medical Research Institute, along with the University of Iowa, announced success in their efforts to create pluripotent stem cells safely from cord blood obtained from donors.

TABLE OF CONTENT

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

[bhandvalkar94]

Global Stem Cell Banking Market Analysis, Key Company Profiles, Types, Applications and Forecast to 2030

Absolute Markets Insights announced the addition of a statistical data titled as, Stem Cell Banking Market to its massive repository. Additionally, it offers extensive research on different dynamic aspects of the businesses to understand the impact of those. Primary and secondary research techniques have been used by analysts for studies data effectively.

The global stem cell banking market is anticipated to reach US$ 15089.64 Mn by 2030 growing at a CAGR of 10% during the forecast period (2021-2030).

Different top key players such as CBR Systems, Inc., Cell Care, CHA Biotech, CordBank New Zealand, Cordlife, Cryo-Cell, CryoHoldco, Cryoviva India, CSG-BIO, Global Cord Blood Corporation., LifeCell International Pvt. Ltd., ReeLabs Pvt. Ltd., Regrow Biosciences Pvt Ltd., Smart Cells International Ltd., Stem Med Pte Ltd, StemCyte, ViaCord and Vita 34 Inc. give the comparative analysis of demand supply chain. In addition to this, it highlights the historical developments, recent trends, and predictions about the future growth of the Stem Cell Banking market.

For more information about this report visit: https://www.absolutemarketsinsights.com/reports/Stem-Cell-Banking-Market-2021---2029-860

Umbilical cord accounted for the largest source in the global stem cell banking market in 2020. Cord blood stem cells can be used in therapies and transplants to treat over 85 ailments that include anaemias (different types), bone marrow cancer, leukaemias (different types), and lymphomas. More than 5,000 clinical trials are using stem cell therapies today.

In the context of medical condition, higher market share in the global stem cell banking market was held by cancer (leukaemias, lymphomas, etc.) in 2020. Stem cells can be used for the treatment of different types of cancer such as acute biphenotypic leukemia, acute lymphoblastic leukemia, acute myelogenous leukemia, acute undifferentiated leukemia, chronic myelogenous leukemia, chronic lymphocytic leukemia, juvenile myelomonocytic leukemia, and juvenile chronic myelogenous leukemia. In regenerative medicine, the use of stem cells has been in vogue for a long time. It is very common in the field of dermatology.

Global Stem Cell Banking Market: Report Scope

By Service Type

Storage

Testing and Processing

Collection

By Source

Umbilical Cord

Placenta

Amniotic Fluid

Bone Marrow

Others

By Medical Condition

Cancer (Leukaemias, Lymphomas, Etc.)

Non-Malignant Blood Disorders (Anaemias, Hereditary Bone Marrow Failure Syndromes, Etc.)

Immune Disorder (Severe Combined Immune Deficiency (SCID), Inherited Immune System Disorders, etc.)

Metabolic Disorders (Leukodystrophy Disorders, Mucopolysaccharidosis (MPS) Storage Diseases, Etc.)

Others

By Application

Disease Treatment & Tissue Regeneration

Clinical Research

Personalized Banking Applications

By Region

North America

Europe

Asia Pacific

Middle East and Africa

Latin America

Contact Us:

Company: Absolute Markets Insights Email Id: sales@absolutemarketsinsights.com Phone: IN +91-740-024-2424 , US +1-510-420-1213 Contact Name: Shreyas Tanna Website: www.absolutemarketsinsights.com/

[siddheshrankamaximize]

Stem Cell Banking Market Trends Analysis , Major Players , Upside Learning up to 2027

Stem Cell Banking Market Overview:

A stem cell bank is a facility, which stores stem cells for future use. Stem cell banking is the process of conserving stem cells at temperatures below the freezing point. These cells used for the treatment of Parkinson's syndrome, cancer, diabetes, heart diseases, and others.

Maximize Market Research has published a comprehensive research and analysis of the Stem Cell Banking Market, which identifies new developments in the Stem Cell Banking Market and gives business insights to organisations. This research assists manufacturers, suppliers, and investors, as well as CEOs, in identifying opportunities and business optimization techniques for increasing their value in the worldwide Stem Cell Banking Market. Provides critical information for well-known organisations that are among the best performers. The research covers present and new markets in depth, as well as an assessment of competitiveness in shifting market circumstances.

List of Key players: Following are the number of key players studied to understand the Stem Cell Banking Market:

1. CCBC 2. CBR Systems, Inc. 3. ViaCord 4. Esperite 5. Vcanbio 6. Boyalife 7. LifeCell 8. Crioestaminal 9. RMS Regrow 10. Cryo-cell 11. Cordlife Group 12. PBKM FamiCord 13. Cells4life 14. Beikebiotech 15. StemCyte 16. Cellsafe Biotech Group 17. PacifiCord 18. Americord 19. Krio 20. Familycord 21. CryoStemcell 22. Stemade Biotech 23. Stem Cell Cluster 24. Lifebank Stem Cell Banking 25. FUJIFILM Cellular Dynamics

Enquiry before buying this premium Report:

https://www.maximizemarketresearch.com/request-sample/13540

This study estimates the size of the Stem Cell Banking Market in terms of both value and volume. It includes a thorough examination of the market's major drivers, restraints, and opportunities. Through the Porter's five forces analysis, the study examines the major elements that contribute to the growth of the Stem Cell Banking Market. Furthermore, the market participants have been profiled, with a particular emphasis on their product offers.

The research also includes data in the form of statistics, facts, and figures, as well as contact information and sales contact information for the global market's leading players. There is a full picture of the global Stem Cell Banking Market 's competitive landscape, with all information gathered and deepened with the SWOT analysis. Opportunities for possible industrial expansion have been identified, as have the competitive threats associated.

The report also discusses critical industry niches such as items or services supplied, downstream fields, end-user customers, historical data figures for revenue and sales, market background, and more. To acquire a better understanding of the companies, global Stem Cell Banking Market-leading main players have been profiled. It offers specific expansions to a variety of high-level industries operating around the globe. The section also includes useful information such as an overview of the firm and its market share, company biographies, and some significant methods used by key companies to build their businesses.

The introduction of new goods and the research involved in the development of innovative products is one of the primary components that is likely to have an impact on the Stem Cell Banking Market. The study provides information on the sales and market growth of various markets on a regional and national scale. This report is to provide a market analysis in terms of growth patterns, prospects, and market players' contributions to market development. The research also examines market demand growth estimates for products and services.

OBJECTIVES OF THE STUDY

To analyse and forecast the market size of the global Stem Cell Banking Market, in terms of value and volume

To identify significant trends and factors driving or inhibiting the market growth

To analyse the opportunities in the market for stakeholders by identifying the high-growth segments

To define, describe, and forecast the market by type, application, and region

To forecast the size (in terms of value and volume) of the market and submarkets by five regions, namely, Asia-Pacific, Europe, North America, the Middle East & Africa, and South America

To strategically analyse each submarket with respect to individual growth trend and their contribution to the market

To analyse competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

To strategically profile the key players and comprehensively analyse their growth strategies

Our Research Methodology:

This research study involves the use of extensive secondary sources such as encyclopedia, directories, and databases to identify and collect information useful for this technical, market-oriented, and commercial study of the Stem Cell Banking Market. Primary sources that include selected experts from related industries and selected suppliers have been interviewed to obtain and verify important information as well as to assess future prospects. As a part of the secondary research process, various sources have been referred to for identifying and collecting information for this study. Secondary sources include annual reports, press releases, and investor presentations of companies; white papers; certified publications, articles from recognized authors; and gold & silver standard websites.

Browse Complete Stem Cell Banking Market Report details and List Of Figures Here:

https://www.maximizemarketresearch.com/market-report/stem-cell-banking-market/13540/

About Us.:

Maximize Market Research has served esteemed clients including Yamaha, Boeing, Sensata, Etnyre, Canada, ALCOR M&A, Microsoft, Harman, and other 200 MNCs worldwide. The Company provides B2B and B2C market research on 5000 high growth emerging technologies & opportunities in Transportation, Chemical, Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.We, at Maximize Market Research, are a strong unified team of industry specialists and analysts across sectors to ensure entire Industry ecosystem is taken in perspective, factoring all recent development, latest trends and futuristic – the technological impact of uniquely specific industries.

Contact Details: Maximize Market Research Pvt. Ltd. Phone: US: +1 774 775 2163; APAC: +91-9607365656 Email: sales@maximizemarketresearch.com Website: www.maximizemarketresearch.com

[jesse-pinkman123]

Cord Blood Banking Services Market Size, Trends, Shares, Insights and Forecast – 2018-2026

Cord blood banking refers to collection and preservation of blood derived from the umbilical cord. Umbilical cord blood is a potential source of progenitor cells, which can be used for reconstitution of tissue, organs, and other functional areas.

Statistics:

The global Cord Blood Banking Services Market is estimated to account for US$ 42.9 Bn in terms of value by the end of 2027.

Global Cord Blood Banking Services Market: Drivers

Advancements in cord blood processing is expected to propel growth of the global cord blood banking services market over the forecast period. For instance, in June 2019, ThermoGenesis Corp., a wholly owned subsidiary of Cesca Therapeutics, entered into a strategic agreement with Cordlife Group Limited to provide its proprietary, next-generation AXP II System, for the rapid processing of cord blood units, to Cordlife's India processing facility.

Global Cord Blood Banking Services Market: Opportunities

R&D of methods to enhance the therapeutic potency of cord blood cells is expected to offer lucrative growth opportunities for players in the global cord blood banking services market. For instance, in January 2020, researchers at Biomedical Research Institute, MEDIPOST Co., Ltd., South Korea, reported analysis of the effects of spheroid umbilical cord blood-derived mesenchymal stem cells (MSCs) and suggested a new therapeutic approach, 3D spheroid formation of MSCs, in order to enhance the regeneration process in the course of osteoarthritis.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/3913

Global Cord Blood Banking Services Market: Restraints

There are various accreditation organizations such as American Association of Blood Banks, American Association of Tissue Banks, Clinical Laboratory Improvement Amendments, Therapeutic Goods Administration, and others, which maintain standard and quality of cord blood banking. Regular updates in the standards and inspection by authorities requires the facilities to update their facilities regularly. These activities involve huge costs and documentation, which may increase final cost of product. This in turn is expected to hinder growth of the market.

Key Takeaways:

The global cord blood banking services market was valued at US$ 26.8 Bn in 2019 and is forecast to reach a value of US$ 42.9 Bn by 2027 at a CAGR of 6.1% between 2020 and 2027.Increasiong prevalence of cancer is expected to assist the market growth.

Public Cord Blood Banking Services segment held dominant position in the global cord blood banking services market in 2019, accounting for 52.7% share in terms of value, owing to increasing advancements in cord blood processing during the forecast period

Market Trends

Major players in the market are focused on adopting M&A strategies to expand their product portfolio. For instance, in September 2019, CBR Systems, Inc. acquired Natera, Inc.’s Evercord cord blood and tissue banking business.

Browse Research Report: https://www.coherentmarketinsights.com/market-insight/cord-blood-banking-services-market-3913

Increasing awareness regarding cord blood banking is expected to aid in growth of the market. For instance, in November 2019, Save the Cord Foundation celebrated World Cord Blood Day.

Regulations

Europe

Joint Accreditation Committee - ISCT – EBMT (JACIE) is a non-profit establishment in Europe for accrediting organizations that provide cell therapy. Its standards currently apply on stem cells derived from sources such as umbilical cord blood, peripheral blood and bone marrow. The scope of JACIE accreditation applies on use of stem cells such as hematopoietic stem cells and therapeutic cells to be used for therapeutic purpose.

Global Cord Blood Banking Services Market: Competitive Landscape  

Major players operating in the global cord blood banking services market include, China Cord Blood Corporation, Cord Blood America, Inc., CBR Systems, Inc., Cordlife Group Ltd., Cryo-Cell International, Inc., StemCyte, Inc., Americord Registry, Cryo-Save Group AV, NeoStem, Inc., Blood Centers of America, and ViaCord, Inc.

Global Cord Blood Banking Services Market: Key Developments

July 2019: CBR Systems, Inc. started the process to transition to next-generation AXP II System of ThermoGenesis, a wholly owned subsidiary of Cesca Therapeutics, for the rapid processing of cord blood units

June 2019: Blood Centers of America partnered with Team Liquid, a multi-regional, professional esports organization, to raise awareness of the importance of blood donation and to encourage donations

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/3913

About Coherent Market Insights:            

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

mailto:sales@coherentmarketinsights.com

U.S. Office:

Name:  Mr. Shah

Coherent Market Insights 1001 4th Ave,

# 3200 Seattle, WA 98154, U.S.

US :  +1-206-701-6702

UK :  +44-020-8133-4027

JAPAN :  +050-5539-1737

[andy1199posts]

Stem Cell Banking Market - Global Leaders & Different Growth Adopted by Them

Stem Cell Banking Market – Global Leaders & Different Growth Adopted by Them

Key Market Players:As of 2017, the global stem cell banking market was dominated by Cord Blood Registry (CBR) Systems (US), Cordlife Group Limited (Singapore), Cryo-Cell International (US), and ViaCord (US). Other key players in the stem cell banking market included Cryo-Save AG (Netherlands), LifeCell International (India), StemCyte (US), Global Cord Blood Corporation (China), Smart Cells…

[kunalcmi]

CORD BLOOD BANKING SERVICES MARKET ANALYSIS (2020-2027)

Umbilical cord blood banking or cord blood banking is the practice of preserving blood from the umbilical cord for future use. Such preserved cord blood is used in medical therapies in the similar fashion as that of stem cells derived from bone marrow.

Cord blood banking refers to collection and preservation of blood derived from the umbilical cord. Umbilical cord blood is a potential source of progenitor cells, which can be used for reconstitution of tissue, organs, and other functional areas.

 Statistics:

The global cord blood banking services market is estimated to account for US$ 42.9 Bn in terms of value by the end of 2027.

 Global Cord Blood Banking Services Market: Drivers

Increasing prevalence of cancer is expected to propel growth of the global cord blood banking services market over the forecast period. For instance, according to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the U.S.

Moreover, increasing number of blood donor centers is also expected to aid in growth of the market. For instance, in April 2020, BioIVT, a provider of research models and services for drug and diagnostic development, started its new blood donor center on the Tufts University campus in Medford, Massachusetts, U.S., to support academic and pharmaceutical researchers involved in COVID-19, cell and gene therapy research.

 Statistics:

North America held dominant position in the global cord blood banking services market in 2019, accounting for 49.0% share in terms of value, followed by Europe and Asia Pacific, respectively

 Figure 1: Global Cord Blood Banking Services Market Share (%) Value, By Region, 2019

Global Cord Blood Banking Services Market: Restraints

Scarcity of compatible cord blood units is a major factor hindering growth of the market. There has been a shortage of cord blood units throughout North America particularly for minorities. Short supply of cord blood units across the globe particularly affects ethnic minorities.

Moreover, the average cost for collection, testing, and processing of cord blood units is around US$ 1,600 with the recurring annual charges of around US$ 100. Such chargeable services include testing for infectious diseases, typing, and contamination. Public banks do not charge for storage and collection of cord blood units. However, the ownership and the availability of blood units will depend on the bank. Such scenario is also expected to limit the market growth.

Global Cord Blood Banking Services Market: Opportunities 

R&D in use of cord blood in the treatment of neurodegenerative disorders is expected to offer lucrative growth opportunities for players in the global cord blood banking services market. For instance, in April 2020, researchers from University of L’Aquila, Italy, reported that suggest that cord blood serum -based eye drops might be successfully used to mitigate retinal neurodegenerative processes such as age-related macular degeneration.    

Moreover, use of cord blood in cancer diagnosis and treatment is also expected to aid in growth of the market. For instance, in March 2020, researchers from Vinmec Healthcare System, Vietnam, reported that cryo umbilical cord blood mononuclear cells source is effective in generating allogeneic dendritic cells and their exosomes can be used for vaccinating against cancer.

Statistics:

The global cord blood banking services market was valued at US$ 26.8 Bn in 2019 and is forecast to reach a value of US$ 42.9 Bn by 2027 at a CAGR of 6.1% between 2020 and 2027.

 Figure 2: Global Cord Blood Banking Services Market Value (US$ Bn), 2016 – 2027

Market Trends/Key Takeaways

Government initiatives to improve cord blood bank licensing is boosting growth of the market. For instance, in December 2019, China's National Health Commission issued a new policy allowing the relevant Provincial Health Commissions to approve cord blood bank licenses in 18 pilot Free Trade Zones in China.

Moreover, launch of new genetic screening tests is also offer conducive environment for market growth. For instance, in November 2019, CBR Systems, Inc., in collaboration with Sema4 –a health intelligence company, launched ReadyGen, a genetic screening test that analyzes a child's DNA for more than 200 conditions that can affect children before the age of 10.

  Request Sample Free Copy of Report here: https://www.coherentmarketinsights.com/insight/request-sample/3913

Download PDF Brochure: https://www.coherentmarketinsights.com/insight/request-pdf/3913

Regulations

U.S.

American Association of Blood Banks (AABB) is a non-profit international association of institutions and individuals who are engaged in cell transplantation and transfusion medicine. The standards framed by the AABB are updated every two years and by its subject matter experts.

 The AABB accredited cord blood banks are eligible to perform following tests upon cord blood banking:

Tests for mothers: HIV-I and II, Hepatitis B and C, Syphilis, HTLV-I and II and CMV

Tests for family: family health history

Cord blood tests: red cell antibodies, CD+34, ABO, Rh, bacterial or fungal contamination and WBC

Whenever cord blood bank is transferred from any AABB accredited bank, the organization requires reporting of patient outcome from such blood bank. It should be noted that AABB accreditation does not need a specific cord blood processing procedure.

 Global Cord Blood Banking Services Market: Competitive Landscape

Major players operating in the global cord blood banking services market include, China Cord Blood Corporation, Cord Blood America, Inc., CBR Systems, Inc., Cordlife Group Ltd., Cryo-Cell International, Inc., StemCyte, Inc., Americord Registry, Cryo-Save Group AV, NeoStem, Inc., Blood Centers of America, and ViaCord, Inc.

 Global Cord Blood Banking Services Market: Key Developments

Major players in the market are focused on adopting partnership strategies to enhance their market share. For instance, in August 2019, StemCyte, Inc. renewed its partnership with Sharp HealthCare, which includes Sharp Mary Birch Hospital for Women & Newborns, a center in the U.S. offering maternity, neonatal, and women's surgical services.

Major players in the market are also focused on launching new products to expand their product portfolio. For instance, in July 2019, Americord Registry launched Placental Tissue 2.0, its newest stem cell banking product, which stores live amniotic membrane.

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions.

 What we provide:

Customized Market Research Services

Industry Analysis Services

Business Consulting Services

Market Intelligence Services

Long term Engagement Model

Country Specific Analysis

Contact Us:

Mr. Shah

Coherent Market Insights Pvt. Ltd.

Address: 1001 4th ave, #3200 Seattle, WA 98154, U.S.

Phone: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Source: https://www.coherentmarketinsights.com/market-insight/cord-blood-banking-services-market-3913

[sapanas]

Cord Blood Banking Services Market Estimated To Lock An Ineffaceable Growth

Cord Blood Banking Services Market Research Report - Global Forecast till 2023, Published by Market Research Future. MRFR Provides Cord Blood Banking Services Industry Updates, Size, Share, Growth, Competitive Landscape, Regional Outlook

Cord Blood Banking Services Market Overview

According to Market Research Future (MRFR), the global market for cord blood banking services is projected to expand at 11.4% CAGR from 2017 to 2023 (forecast period).

Umbilical cord blood is an abundant source of stem cells capable of treating more than 80 genetic diseases. Stem cells can also combat long-lasting illnesses such as diabetes, cancer, immune diseases, and blood disorders. Although a small amount of cord blood can be obtained from a single umbilical cord, it contains a large number of stem cells that can be developed and stored for future use. After delivery, these cells are collected from hospitals and nursing homes and deposited in cord blood banks (average 20–25 years) for potential use. Now, companies are seeking to raise awareness of the benefits of cord blood storage. For example, in 2014, the Center for Transfusion Medicine and the Cord Blood Registry combined their resources to initiate a multi-year campaign to raise awareness of cord blood cells.

Read more news on: https://www.medgadget.com/2020/06/cord-blood-banking-services-market-size-2020-covid-19-impact-analysis-global-industry-research-report-growth-technology-development-trends-swot-analysis-top-company-profile-key-regions-foreca.html

Cord Blood Banking Services Market Dynamics

Factors such as increasing the use of cord blood in the treatment of chronic diseases, raising the focus of federal agencies on setting up public banking units, raising awareness of this treatment line, and increasing number of facilities across the region are accelerating market growth.

However, strict regulatory standards, ethical concerns, and the dilemma of choosing private or public banks are vital factors that impede the growth of the market. In addition, the high cost of storage, collection, and risk of unusability of a private bank-stored unit further reduces the growth of the global market for cord blood banking services.

Cord Blood Banking Services Market Segmentation

The global cord blood banking services market has been segmented based on storage service, component, application, and end-user.

Based on storage service, the global market for cord blood banking services has been segmented into hybrid cord blood banks, private cord blood banks, and public cord blood banks.

Based on components, the global market for cord blood banking services has been segmented into cord blood, cord tissue, placenta, and others.

Based on the application, the global market for cord blood banking services has been segmented into cancers, immune disorders, blood disorders, metabolic disorders, and osteoporosis.

Based on end-user, the global market for cord blood banking services has been segmented into hospitals (medical applications), research institutes (scientific research), pharmaceutical research (drug discovery), and others.

Cord Blood Banking Services Market Regional Analysis

The global cord blood banking services market consists of four regions: the Americas, Europe, Asia Pacific, and the Middle East and Africa.

The Americas region held the largest market share of the global market for cord blood banking services due to the increasing number of service providers, increasing awareness of the long-term benefits of cord blood storage, increasing investment in public banking, and reduction in storage costs. In addition, the U.S. is contributing to a significant market share for the global cord blood banking industry. Factors include a rise in per capita income, an increase in the number of storage service providers, and a high acceptance rate for new technology attributed to the largest market share.

The European cord blood banking market is the second-largest market, followed by the Asia Pacific region.

The Asia Pacific region is projected to dominate the global market for cord blood banking services in terms of growth in the forecast period. Although the region currently has a small share of the global market, it is projected to have enormous growth potential as a result of increasing awareness of stem cell banking and significant improvements in health care reforms in countries such as Malaysia, India, Indonesia, and China. Moreover, Asia Pacific is a mostly unexplored regional market compared to developed regions, which is why it provides better opportunities for business growth.

The Middle East region is anticipated to expand at a steady pace due to growing R&D activities in the healthcare sector and the overall growth of healthcare infrastructure.

Cord Blood Banking Services Market Key Players

Some of the leading participants in the global cord blood banking services market are Cordlife Group Limited (Singapore), China Cord Blood Corporation (China), Cord Blood America, Inc. (U.S.), Cryo-Cell International, Inc. (U.S.), CBR Systems, Inc. (U.S.), Cryo-Save AG (Netherland), Lifeforce Cryobank Sciences Inc. (U.S.), California Cryobank Stem Cell Services LLC (U.S.), Virgin Health Bank (Qatar), StemCyte, Inc. (India), ViaCord, Inc. (U.S.), Norton Healthcare, Inc. (U.S.), CordVida (Brazil), CryoHoldco de Latinoamerica, S.A.P.I. De C.V. (Mexico), The University of Colorado Cord Blood Bank (U.S.), Vita 34 International (Germany), Maze Cord Blood Laboratories (U.S.), Lifebank USA (U.S.), Cryoviva Biotech Pvt. Ltd (India), CariCord (U.S.), Genecord (U.S.), AlphaCord (U.S.), Cells4Life (UK), Carter BloodCare (U.S.), Michigan Blood (U.S.), Viacord Processing Laboratory (VPL) (U.S.), LifeCell International Pvt. Ltd (India), FamilyCord (U.S.), Stem Cell Cryobank Inc. (U.S.), New Jersey Cord Blood Bank (U.S.), Americord Registry (U.S.), CorCell (U.S.), and others.

Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/cord-blood-banking-services-market-5817

[aditi3019]

Cord Blood Banking Services Market 2020 Global Analysis, Segments, Top Key Players, Industry Growth, Drivers and Recent Trends by Forecast to 2023

Major players of the Cord Blood Banking Services Market are facing hurdles keeping their production facilities operational due to the paucity of adequate personnel and resources amidst the COVID-19 (Coronavirus) outbreak. Get a first-hand peek into the key drivers and threats to the Cord Blood Banking Services Market to make your company future-ready post the pandemic. Avail our market reports at unbelievable prices to capitalize on opportunities.

Cord Blood Banking Services Market Insights

The growing awareness of the usefulness of stem cells in treating various metabolic, immunological, and blood disorders is probably one of the main drivers of the global umbilical cord banking market over the anticipated period. Stem cells preserve the basic genetic formation of an individual in the form of pluripotent cells that can be converted into a wide variety of cell types in the human body. This makes them very important in the field of research for diseases such as blood-related diseases, immune system diseases, cancers, and metabolic disorders.

Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/5817

The umbilical cord blood bank remains the most effective means of acquiring, storing, and mobilizing stem cells, so the cord blood bank service market is likely to grow over the forecast period. Growing public support for the cord blood bank sector and growing private investment in the field are also likely to be crucial for the global umbilical blood bank services market during the forecast period. Owing to the adequate storage facilities and fragile nature of cord blood and stem cells must be in place before attempts are made to repair and obtain cord blood stem cells. Like normal blood, cord blood and stem cells also require significant cooling and hygiene efforts to maintain stem cells in a viable manner. Increasing government support for health care expansion and increasing acceptance and research of stem cells should be an important mechanism for the global umbilical cord blood banking market during the forecast period.

Cord Blood Banking Services Market Segmentation

The global cord blood banking services market is bifurcated on the basis of storage, component service, application, and end-user.

The storage service segment of the global cord blood banking services market can be segmented into private cord blood banks, hybrid cord blood banks, and public cord blood banks, and.

Based on the components, the global market can be classified into cord blood, placenta, cord tissue, and others.

Based on the application, the global cord blood banking services market can be segmented into cancers, immune disorders, blood disorders, metabolic disorders, and osteoporosis.

The global market, based on the end-user, is segregated into hospitals (medical applications), research institutes (scientific research), pharmaceutical research (drug discovery), and others.

Cord Blood Banking Services Market Regional Outlook

The America region is responsible for most of the global umbilical cord blood market due to the growing number of providers, the growing awareness of the long term benefits of cord blood storage, the increased investment in public banks, and cost reduction. involved in storage. In addition, the United States contributes to significant market share in the global umbilical cord blood banking sector. Factors such as per capita income growth, the growing number of storage service providers, and the high level of acceptance of advanced technologies attributed to increased market share. The European umbilical cord blood banking market is the second-largest market, followed by the Asia Pacific region.

The Asia Pacific region is expected to dominate the global umbilical cord blood banking market in terms of growth rates over the forecast period. Although the region currently has minimal global market share, it is expected to show tremendous growth potential due to growing stem cell bank awareness and a significant improvement in health care reforms in countries around the world such as Malaysia, India, Indonesia, and China. In addition, the Asia Pacific region is a relatively untapped regional market compared to developed regions, which also explains why it offers better opportunities for business growth.

The Middle East region is expected to grow steadily due to factors such as increased health R&D and extensive development of health infrastructure.

Cord Blood Banking Services Market Key Players

Some of the industry giants in the global cord blood banking services market are CBR Systems, Inc., Cord Blood America, Inc, Cordlife Group Limited, Cryo-Cell International, Inc., China Cord Blood Corporation, Cryo-Save AG, ViaCord, Inc., Virgin Health Bank, California Cryobank Stem Cell Services LLC, Michigan Blood, StemCyte, Inc., Norton Healthcare, Inc., Lifeforce Cryobank Sciences Inc., Vita 34 International, Viacord Processing Laboratory (VPL), CordVida , CryoHoldco de Latinoamerica, S.A.P.I. De C.V., Maze Cord Blood Laboratories, The University of Colorado Cord Blood Bank, CorCell, Lifebank USA, Genecord, Cryoviva Biotech Pvt. Ltd, , AlphaCord, FamilyCord, Cells4Life, , CariCord, LifeCell International Pvt. Ltd, Stem Cell Cryobank Inc.,New Jersey Cord Blood Bank, Carter BloodCare, Americord Registry, and others.

Cord Blood Banking Services Industry Updates

Participating in the world cold blood day celebration, the global leader in newborn stem cell banking, announced today a new genetic service developed over the past couple of years as part of a strategic alliance with sema4.

Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/cord-blood-banking-services-market-5817

[adwaitcoherent]

In 2019, US$ 26.8 Bn to US$ 42.9 Bn in 2027, the global cord blood banking services market is predicted to show exponential growth

From 2019 till 2027 With CAGR of 6.1%, increasing prevalence of cancer is expected to assist the market growth of the global cord blood banking services market.

Request for Sample PDF Copy: https://www.coherentmarketinsights.com/insight/request-sample/3913

Figure 1: Global Cord Blood Banking Services Market Share (%) Value, By Region, 2019

Statistics: The global cord blood banking services market is estimated to account for US$ 42.9 Bn in terms of value by the end of 2027.

Global Cord Blood Banking Services Market: Drivers Advancements in cord blood processing is expected to propel growth of the global cord blood banking services market over the forecast period. For instance, in June 2019, ThermoGenesis Corp., a wholly owned subsidiary of Cesca Therapeutics, entered into a strategic agreement with Cordlife Group Limited to provide its proprietary, next-generation AXP II System, for the rapid processing of cord blood units, to Cordlife's India processing facility.

Global Cord Blood Banking Services Market: Opportunities R&D of methods to enhance the therapeutic potency of cord blood cells is expected to offer lucrative growth opportunities for players in the global cord blood banking services market. For instance, in January 2020, researchers at Biomedical Research Institute, MEDIPOST Co., Ltd., South Korea, reported analysis of the effects of spheroid umbilical cord blood-derived mesenchymal stem cells (MSCs) and suggested a new therapeutic approach, 3D spheroid formation of MSCs, in order to enhance the regeneration process in the course of osteoarthritis.

Figure 2: Global Cord Blood Banking Services Market Value (US$ Bn), 2016 – 2027

Global Cord Blood Banking Services Market: Restraints There are various accreditation organizations such as American Association of Blood Banks, American Association of Tissue Banks, Clinical Laboratory Improvement Amendments, Therapeutic Goods Administration, and others, which maintain standard and quality of cord blood banking. Regular updates in the standards and inspection by authorities requires the facilities to update their facilities regularly. These activities involve huge costs and documentation, which may increase final cost of product. This in turn is expected to hinder growth of the market.

Key Takeaways: The global cord blood banking services market was valued at US$ 26.8 Bn in 2019 and is forecast to reach a value of US$ 42.9 Bn by 2027 at a CAGR of 6.1% between 2020 and 2027.Increasiong prevalence of cancer is expected to assist the market growth.

Public Cord Blood Banking Services segment held dominant position in the global cord blood banking services market in 2019, accounting for 52.7% share in terms of value, owing to increasing advancements in cord blood processing during the forecast period

Market Trends Major players in the market are focused on adopting M&A strategies to expand their product portfolio. For instance, in September 2019, CBR Systems, Inc. acquired Natera, Inc.’s Evercord cord blood and tissue banking business. Increasing awareness regarding cord blood banking is expected to aid in growth of the market. For instance, in November 2019, Save the Cord Foundation celebrated World Cord Blood Day.

Regulations Europe Joint Accreditation Committee - ISCT – EBMT (JACIE) is a non-profit establishment in Europe for accrediting organizations that provide cell therapy. Its standards currently apply on stem cells derived from sources such as umbilical cord blood, peripheral blood and bone marrow. The scope of JACIE accreditation applies on use of stem cells such as hematopoietic stem cells and therapeutic cells to be used for therapeutic purpose.

Global Cord Blood Banking Services Market: Competitive Landscape   Major players operating in the global cord blood banking services market include, China Cord Blood Corporation, Cord Blood America, Inc., CBR Systems, Inc., Cordlife Group Ltd., Cryo-Cell International, Inc., StemCyte, Inc., Americord Registry, Cryo-Save Group AV, NeoStem, Inc., Blood Centers of America, and ViaCord, Inc.

Global Cord Blood Banking Services Market: Key Developments July 2019: CBR Systems, Inc. started the process to transition to next-generation AXP II System of ThermoGenesis, a wholly owned subsidiary of Cesca Therapeutics, for the rapid processing of cord blood units June 2019: Blood Centers of America partnered with Team Liquid, a multi-regional, professional esports organization, to raise awareness of the importance of blood donation and to encourage donations

Segmentation: Global Cord Blood Banking Services Market, By Type Global Cord Blood Banking Services Market, By Region Company Profiles Buy this Research Report: https://www.coherentmarketinsights.com/insight/buy-now/3913

About Us: Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We do offer wide range of services such as Industry analysis, Consulting services, Market Intelligence, Customized research services and much more. We have expertise in many fields such as healthcare, chemicals and materials, Automation, semiconductors, electronics, energy, food and beverage, packaging and many more. Visit our website to know more.

Contact Us: Mr. Shah Coherent Market Insights 1001 4th Ave.  #3200  Seattle, WA 98154 Tel: +1-206-701-6702 Email: sales@coherentmarketinsights.com

[marketresearchhealthcarefuture]

Cord Blood Banking Services Market Size 2021, Covid 19 Impact Analysis

Cord Blood Banking Services Market Overview

According to Market Research Future (MRFR), the global market for cord blood banking services is projected to expand at 11.4% CAGR from 2017 to 2023 (forecast period).

Umbilical cord blood is an abundant source of stem cells capable of treating more than 80 genetic diseases. Stem cells can also combat long-lasting illnesses such as diabetes, cancer, immune diseases, and blood disorders. Although a small amount of cord blood can be obtained from a single umbilical cord, it contains a large number of stem cells that can be developed and stored for future use. After delivery, these cells are collected from hospitals and nursing homes and deposited in cord blood banks (average 20–25 years) for potential use. Now, companies are seeking to raise awareness of the benefits of cord blood storage. For example, in 2014, the Center for Transfusion Medicine and the Cord Blood Registry combined their resources to initiate a multi-year campaign to raise awareness of cord blood cells.

Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/5817

Cord Blood Banking Services Market Dynamics

Factors such as increasing the use of cord blood in the treatment of chronic diseases, raising the focus of federal agencies on setting up public banking units, raising awareness of this treatment line, and increasing number of facilities across the region are accelerating market growth.

However, strict regulatory standards, ethical concerns, and the dilemma of choosing private or public banks are vital factors that impede the growth of the market. In addition, the high cost of storage, collection, and risk of unusability of a private bank-stored unit further reduces the growth of the global market for cord blood banking services.

Cord Blood Banking Services Market Segmentation

The global market for cord blood banking services has been segmented based on storage service, component, application, and end-user.

Based on storage service, the global market for cord blood banking services has been segmented into hybrid cord blood banks, private cord blood banks, and public cord blood banks.

Based on components, the global market for cord blood banking services has been segmented into cord blood, cord tissue, placenta, and others.

Based on the application, the global market for cord blood banking services has been segmented into cancers, immune disorders, blood disorders, metabolic disorders, and osteoporosis.

Based on end-user, the global market for cord blood banking services has been segmented into hospitals (medical applications), research institutes (scientific research), pharmaceutical research (drug discovery), and others.

Cord Blood Banking Services Market Regional Analysis

The global cord blood banking services market consists of four regions: the Americas, Europe, Asia Pacific, and the Middle East and Africa.

The Americas region held the largest market share of the global market for cord blood banking services due to the increasing number of service providers, increasing awareness of the long-term benefits of cord blood storage, increasing investment in public banking, and reduction in storage costs. In addition, the U.S. is contributing to a significant market share for the global cord blood banking industry. Factors include a rise in per capita income, an increase in the number of storage service providers, and a high acceptance rate for new technology attributed to the largest market share.

The European cord blood banking market is the second-largest market, followed by the Asia Pacific region.

The Asia Pacific region is projected to dominate the global market for cord blood banking services in terms of growth in the forecast period. Although the region currently has a small share of the global market, it is projected to have enormous growth potential as a result of increasing awareness of stem cell banking and significant improvements in health care reforms in countries such as Malaysia, India, Indonesia, and China. Moreover, Asia Pacific is a mostly unexplored regional market compared to developed regions, which is why it provides better opportunities for business growth.

The Middle East region is anticipated to expand at a steady pace due to growing R&D activities in the healthcare sector and the overall growth of healthcare infrastructure.

Cord Blood Banking Services Market Key Players

Some of the leading participants in the global cord blood banking services market are Cordlife Group Limited (Singapore), China Cord Blood Corporation (China), Cord Blood America, Inc. (U.S.), Cryo-Cell International, Inc. (U.S.), CBR Systems, Inc. (U.S.), Cryo-Save AG (Netherland), Lifeforce Cryobank Sciences Inc. (U.S.), California Cryobank Stem Cell Services LLC (U.S.), Virgin Health Bank (Qatar), StemCyte, Inc. (India), ViaCord, Inc. (U.S.), Norton Healthcare, Inc. (U.S.), CordVida (Brazil), CryoHoldco de Latinoamerica, S.A.P.I. De C.V. (Mexico), The University of Colorado Cord Blood Bank (U.S.), Vita 34 International (Germany), Maze Cord Blood Laboratories (U.S.), Lifebank USA (U.S.), Cryoviva Biotech Pvt. Ltd (India), CariCord (U.S.), Genecord (U.S.), AlphaCord (U.S.), Cells4Life (UK), Carter BloodCare (U.S.), Michigan Blood (U.S.), Viacord Processing Laboratory (VPL) (U.S.), LifeCell International Pvt. Ltd (India), FamilyCord (U.S.), Stem Cell Cryobank Inc. (U.S.), New Jersey Cord Blood Bank (U.S.), Americord Registry (U.S.), CorCell (U.S.), and others.

TABLE OF CONTENT

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

…TOC Continued…

Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/cord-blood-banking-services-market-5817